NIH halts own embryonic stem cell research (Morning Read)

Highlights of the important and interesting in the world of healthcare:

NIH halts own stem cell research. The National Institutes of Health Monday ordered all of its researchers conducting research on human embryonic stem cells to halt their experiments, according to the Washington Post’s The Checkup blog.

Marker for tuberculosis? A blood-based genomic marker for tuberculosis may identify people who are at risk for developing the disease, according to researchers at Nationwide Children’s Hospital in Columbus, Ohio.

Drug-eluting stent works. Cordis Corp., a Johnson and Johnson subsidiary, announced at the European Society of Cardiology in Stockholm that tests done ten years after its first patient was treated with the company’s CYPHER Sirolimus-eluting coronary stent have shown “outstanding long-term efficacy and safety.”

What I didn’t learn in residency. Running a business — not something newly minted pediatrician Sandy Chung learned in residency. But Chung ended up liking what she learned on the job.

Three ways hospitals waste money. Even as hospitals try to reduce costs with job cuts and other efforts, they may be losing money in unexpected places, says Becker’s Hospital Review.

End of recession? If you squint just the right way at new numbers from a quarterly “innovation index” released by the University of Michigan in Dearborn, you might believe Michigan sees the light at the end of the recession tunnel, writes Xconomy Detroit.